Alexza Pharmaceuticals

Alexza Pharmaceuticals is owned by Grupo Ferrer. Grupo Ferrer has a direct presence in 2 countries.

View the org chart displaying its 5 main executives

Most searched biographies at Alexza Pharmaceuticals

• Tatjana Naranda, President and Chief Operating Officer
• Stacy Palermini, Senior Vice President, Finance
• Wolfgang Schmid, Vice President, Manufacturing and Operations

Create your alert
to follow the executive moves at Alexza Pharmaceuticals.

Grupo Ferrer has 1,837 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• Molex has announced the acquisition of Vectura Group  (posted on September 23 2024).
• Agilent Technologies has acquired BioVectra (posted on September 23 2024).
• OXB will change its company name to OXB on Sep 18, 2024. (posted on September 18 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Robert Langer - Board Member at Moderna
• Paul Meister - Chairman of the Board at Amneal Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Alexza Pharmaceuticals

Social media about Alexza Pharmaceuticals

• Alexza Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Alexza Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Tatjana Naranda

Call Alexza Pharmaceuticals at +1 650...

View the org chart

Register to receive your alert

Report an error